Optimal Timing of Double-Wire Technique For Biliary Cannulation at ERCP

October 23, 2015 updated by: Duke University
The purpose of this study is to give doctors who perform Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures a better idea as to the best techniques to use in order to examine the bile duct as quickly and safely as possible.

Study Overview

Detailed Description

Sometimes, in the course of a regular ERCP procedure, techniques used by the doctor to pass a wire into the bile duct can result in the pancreas duct being entered instead. When this happens, the doctor may either remove the wire (known as "single wire" technique) or leave it in and use a second wire ("double wire") to enter the bile duct. This study will try to determine whether the "double wire" technique or the "single wire" technique removing the wire is the safest and most efficient.

Study Type

Interventional

Enrollment (Actual)

161

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients undergoing ERCP with primary intent to cannulate the bile duct
  2. Written informed consent

Exclusion Criteria:

  1. Age < 18 years
  2. Non-naive papilla (previous sphincterotomy)
  3. Surgically altered anatomy
  4. Known/suspected pancreas divisum
  5. Suspected SOD/biliary manometry
  6. Prior ERCP/stent within 3 months
  7. ERCP performed in the Operating Room or at Duke North
  8. Pregnancy/breast-feeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: single wire technique
single wire technique in patients undergoing ERCP with biliary cannulation
Active Comparator: Double wire technique
double-wire technique in patients undergoing ERCP with biliary cannulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success of biliary cannulation
Time Frame: 10 minutes after randomization
The primary outcome is incidence of successful deep biliary cannulation within 10 minutes.
10 minutes after randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success of biliary cannulation
Time Frame: 2 days after the procedure
Number of attempts required for successful biliary cannulation
2 days after the procedure
Time to successful biliary cannulation
Time Frame: 2 days after the procedure
2 days after the procedure
Post-ERCP pancreatitis
Time Frame: 2 days after the procedure
2 days after the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Mahfuzul Haque, MD, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

November 19, 2014

First Submitted That Met QC Criteria

November 20, 2014

First Posted (Estimate)

November 21, 2014

Study Record Updates

Last Update Posted (Estimate)

October 26, 2015

Last Update Submitted That Met QC Criteria

October 23, 2015

Last Verified

November 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endoscopic Retrograde Cholangiopancreatography

3
Subscribe